▲ SURGE

Zentalis Pharmaceuticals, Inc.

+49.5%
ZNTLNASDAQHealthcare2026-04-10
6.61
收盘价
4.42
前收盘价
+49.55%
涨幅
3.4x
量比

暴涨原因

2026년 3월 27일, H.C. Wainwright는 Zentalis Pharmaceuticals(ZNTL)에 대한 주식 투자의견을 재확인하고 목표 주가를 10달러($10)로 유지했습니다.

  • ·2026년 3월 27일, H.C. Wainwright는 Zentalis Pharmaceuticals(ZNTL)에 대한 주식 투자의견을 재확인하고 목표 주가를 10달러($10)로 유지했습니다.

相关新闻

Zenas BioPharma Prices $300M Concurrent Offerings Of $200M 2.50% Convertible Senior Notes Due 2032 And 5M Shares At $20 To Fund Obexelimab Launch - Zenas BioPharma (NASDAQ:ZBIO)
Benzinga2026-03-27
Zoetis Inc (ZTS) Stock Price Down 3.29% on Mar 18
Gurufocus2026-03-18
H.C. Wainwright reiterates Zentalis stock rating, $10 target By Investing
Au.Investing2026-03-27
HC Wainwright & Co. Reiterates Buy on Zenas BioPharma, Maintains $44 Price Target - Zenas BioPharma (NASDAQ:ZBIO)
Benzinga2026-03-17
Nektar stock up on trial data for eczema drug (NKTR:NASDAQ)
Seekingalpha2026-02-10

技术分析

信号
布林上轨突破超买MACD看涨站上SMA20
关键指标
87.02RSI (14)
2.85SMA 20
0.86Bollinger Lower
4.84Bollinger Upper
2.85Bollinger Mid
0.45MACD
0.11MACD Signal
0.34MACD Hist
查看股票详情返回暴涨股列表
Zentalis Pharmaceuticals, Inc. +49.5% 暴涨分析 (2026-04-10) | Alpha Lenz